General Session Presentations

Strategy Driven Informatics: Ensuring Value Realization
Jason Bronfeld, Executive Director, Preclinical & Pharmaceutical Development Informatics, Bristol-Myers Squibb

This presentation will illustrate the linkage between business strategy, information management strategy and IM investment in a research setting. It will also discuss value centric planning, implementation and benefits realization with a real-world case study and show how an anchoring IM strategy expressing a multi-year view, creates buy-in, delivers superior value and provides an architecture for expansion. The presentation will discuss how industry solutions, not custom solutions, create the most value for each dollar invested.

Reinventing Pharmaceutical Development & Marketed Product Support
Paul McKenzie, Head, Pharmaceutical Development & Manufacturing Sciences, Johnson & Johnson

We are all familiar with the old adage “better-faster-cheaper, pick two.” However in today’s world of pharmaceutical development and marketed product support, all three are needed and needed now. Development groups are tasked with moving diverse and complex pipelines forward in record time with undivided attention required for both product quality and safety and cost of manufacturing. These challenges don’t require incremental change in the development operating model but revolutionary change in our model. In this talk, we will discuss activities ongoing to meet these challenges. We will discuss the changes required for the processes, plants and people to ensure successful commercial products.

The Role of Enterprise Cloud Computing in Drug Discovery – Fact or Fiction?
Ashley George, Ph.D., Director of the Strategic IT portfolio for Discovery, GlaxoSmithKline

To date, there has been substantial hype on the potential of enterprise cloud computing and its potential ability to transform the collaboration and business process aspects of pharmaceutical Drug Discovery. During the presentation, we will discuss clouds, what is a cloud, the possible impact of cloud hosting to the drug discovery process, and investigate novel proof of concepts. The presentation will end with some pragmatic points to consider around utilising cloud technology for Drug Discovery.

Symyx Software Update, Overview, and Vision
Trevor Heritage, Ph.D., President

This session will provide an update on the current R&D market, strategic vision, and direction of Symyx Software.

Symyx Software Roadmap
John McCarthy, VP Product Management and Strategy

Session will focus on updating attendees on the latest software releases from Symyx and the 2010 software roadmap. In the context of supporting an electronic lab environment topics covered will include Symyx Notebook for a variety of scientific disciplines, how the experimental results captured in Symyx Notebook can be mined by Isentris, Excel and SharePoint supporting collaborative decision support, how new Laboratory Operations software integrates the “supply chain” of the electronic laboratory environment for improved project collaboration and workflow orchestration and advancements in our foundation technologies in chemistry supporting the ever increasing proportion of research performed on large molecules and biologics.